Skip to main content
. 2014 Jun 1;20(4):483–491. doi: 10.1007/s10989-014-9413-0

Fig. 5.

Fig. 5

ACE inhibitory activity of β-lactoglobulin (a, b) and WPC derived peptide fractions (c, d). β-lactoglobulin fractions of molecular mass <3 kDa (a), 3–10 kDa (b). WPC fractions of molecular mass <3 kDa (c), 3–10 kDa (d). ACE inhibitory activity was reported as IC50 i.e. the concentration of the inhibitor required to inhibit 50 % of the DPP-IV activity under the assay conditions